AKT1 and breast carcinoma: PD inhibits the migration, invasion, and growth of MDA-MB-231 human breast cancer cells by suppressing the EGFR-mediated Akt and MAPK pathways and by inhibiting the phosphorylation of Akt and mTOR (18).